Oxford Nanopore Technologies
Oxford Nanopore has developed a new generation of DNA/RNA sequencing technology. It is the only sequencing technology that offers real-time analysis in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths.
Latest Oxford Nanopore Technologies Content
Whitepaper
Sequencing Solutions for Microbiology and Infectious Disease Research
Discover cutting-edge whole-genome sequencing technology that offers unparalleled accuracy and completeness in microbial genome assembly, providing essential insights into pathogen surveillance and antimicrobial resistance.
Webinar
Enhanced Microbial Profiling and Metagenomics With Nanopore Sequencing
In this webinar, you’ll hear from two experts about their research into microbial communities and the impact of nanopore sequencing technologies on their work.
Product News
Oxford Nanopore Technologies Collaborates With Twist Bioscience To Launch Pharmacogenomics Beta Programme and Advance Personalized Medicine
New workflow to provide unambiguous genetic results in a single assay, alleviating the need for time-consuming and costly follow-up tests.
Product News
Oxford Nanopore Technologies Launches Compatible Products Programme To Enhance Genomic Sequencing Ecosystem
Oxford Nanopore Technologies announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products.
Whitepaper
Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.
Product News
Oxford Nanopore Launches PromethION 2 Integrated Into Open Early Access
The PromethION 2 Integrated sets a new standard for convenience and efficiency in DNA, RNA, and cDNA sequencing. With its onboard computing capabilities, the self-contained device is bringing high-quality sequencing to a wider range of labs.
Webinar
Profiling Age and Body Fluid DNA Methylation Markers
On-Demand
In this webinar, our expert speaker will present a new approach – using nanopore adaptive sampling for comprehensive methylation profiling.
Product News
Lonza and Oxford Nanopore To Collaborate on Novel Test To Accelerate Analysis of mRNA Products
Collaboration aims to commercialize a Current Good Manufacturing Practice (cGMP) validated test to enable advanced and innovative analysis for multiple critical quality attributes of mRNA products.
Industry Insight
Shaping the Future of Genomic Medicine
In this interview, James Brayer delves into some of the current obstacles hindering the widespread adoption of genomic medicine and highlights how nanopore-based sequencing can help to address them.
Product News
New State-of-the-Art Genomic Services Facility Opening in the UK
Azenta Life Sciences has selected Oxford, UK, a key European life sciences hub, as the location for its next GENEWIZ Multiomics and Synthesis Solutions site. The site will feature a new state-of-the-art genomics lab scheduled to open in early 2024.
Advertisement
